Literature DB >> 29297506

Haematological cancer: Favourable outcomes with CAR T cells.

Diana Romero.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29297506     DOI: 10.1038/nrclinonc.2017.208

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

2.  Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

Authors:  Stephen J Schuster; Jakub Svoboda; Elise A Chong; Sunita D Nasta; Anthony R Mato; Özlem Anak; Jennifer L Brogdon; Iulian Pruteanu-Malinici; Vijay Bhoj; Daniel Landsburg; Mariusz Wasik; Bruce L Levine; Simon F Lacey; Jan J Melenhorst; David L Porter; Carl H June
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

  2 in total
  2 in total

Review 1.  Solid Tumors Challenges and New Insights of CAR T Cell Engineering.

Authors:  Safa Tahmasebi; Reza Elahi; Abdolreza Esmaeilzadeh
Journal:  Stem Cell Rev Rep       Date:  2019-10       Impact factor: 5.739

2.  Challenges of Cellular Therapy During the COVID-19 Pandemic.

Authors:  Kamal Kant Sahu; Sikander Ailawadhi; Natalie Malvik; Jan Cerny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.